Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Pharmaceuticals
  6. /
  7. FDC Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksPharmaceuticalsFDC Ltd

FDC Ltd Stock Price Today (NSE: FDC)

FDC Ltd

FDCPharmaceuticals
₹321.10₹8.80 (2.67%)↓
As on 30 Mar 2026, 12:05 pm ISTMarket Closed

Fundamental Score

...

FDC Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

FDC Ltd share price today is ₹321.10, down 2.67% on NSE/BSE as of 30 March 2026. FDC Ltd (FDC) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹6.65K (Cr). The 52-week high for FDC share price is ₹527.80 and the 52-week low is ₹317.75. At a P/E ratio of 29.48x, FDC is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 11.83% and a debt-to-equity ratio of 0.01.

FDC Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-2.67%

Returns & Performance

Poor

ROE

11.83%
Average

ROCE

15.90%
Excellent

OPM (5Y)

17.28%
Good

Div Yield

1.23%

FDC Ltd Valuation Check

Average

P/E Ratio

29.48x
Poor

Industry P/E

31.77x
Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Market Cap

6.65K (Cr)

Growth Engine

Poor

Profit Growth (Q)

-60.62%
Poor

Sales Growth (Q)

-7.94%
Poor

Sales Growth (5Y)

9.46%
Poor

EPS Growth (5Y)

2.92%
Poor

Profit Growth (5Y)

1.92%

Balance Sheet Health

Excellent

Debt to Equity

0.01x
Excellent

Int. Coverage

68.79x

Free Cash Flow (5Y)

607.55 (Cr)

Shareholding

Excellent

Promoter

69.66%
Poor

FII

2.43%
Average

DII

6.81%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

FDC Share Price Analysis: ROCE Efficiency and Competitive Positioning

The pharmaceutical industry, characterized by high research and development costs and stringent regulatory hurdles, places a premium on efficient capital allocation. In this context, understanding the drivers of profitability and Return on Capital Employed (ROCE) is crucial for evaluating companies. This analysis focuses on the performance of FDC Ltd, examining its ROCE efficiency and comparing it to its peers. Currently, the FDC share price stands at ₹368.450012, with a Price-to-Earnings (PE) ratio of 29.48 and a ROCE of 15.9%. This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra.

FDC's 15.9% ROCE indicates the company's ability to generate profits from its capital investments. A higher ROCE generally signifies a stronger competitive advantage or "moat." In FDC's case, the ROCE contributes to the company's ability to reinvest in research and development, marketing, and other growth initiatives. This self-sustaining cycle can lead to long-term value creation. Compared to peers like Mankind Pharma Ltd, differences in ROCE might reflect variations in product mix, operational efficiency, or capital structure. While a direct comparison of management quality is difficult to quantify without deeper qualitative analysis, variations in financial metrics can hint at differences in strategic decision-making and capital allocation skills. For example, Mankind Pharma Ltd may exhibit differences in revenue per employee or sales growth which indirectly impacts ROCE due to better efficiencies.

Furthermore, analyzing the components of ROCE, such as net operating profit margin and capital turnover, can provide deeper insights into FDC’s operational efficiency. Comparing these components to those of Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd can reveal relative strengths and weaknesses. A higher ROCE, if sustainable, translates to a greater ability to generate free cash flow and return value to shareholders. However, investors should consider the quality of earnings and the sustainability of the ROCE when assessing the long-term potential of the company.

In conclusion, FDC's ROCE of 15.9% provides valuable insights into its profitability and capital efficiency. While the current FDC share price reflects market expectations, a thorough understanding of its ROCE, coupled with comparisons to its peers, allows for a more informed assessment of its intrinsic value and long-term investment potential. Further investigation into the drivers of FDC's ROCE, and a continued monitoring of its competitive landscape, is recommended.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

FDC Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of FDC across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Excellent ROCE Performance (15.90%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (17.28%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Conservative Debt Levels (D/E: 0.01)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (68.79x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹607.55 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (69.66%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Profit Decline Concern (-60.62%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-7.94%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Weak Earnings Growth (2.92% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (1.92% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Limited Institutional Interest (FII+DII: 9.24%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

FDC Ltd Financial Statements

Comprehensive financial data for FDC Ltd including income statement, balance sheet and cash flow

About FDC (FDC Ltd)

FDC Ltd is a pioneering pharmaceutical company deeply rooted in the Indian subcontinent, with expanding influence across international markets. It's an organisation driven by innov...ation, continually researching and developing novel therapeutic solutions. Their core strength lies in crafting accessible, high-quality medications that address a diverse range of health needs. FDC is synonymous with robust manufacturing practices, ensuring adherence to the most stringent global regulatory standards. They are deeply committed to improving patient outcomes. FDC invests heavily in cutting-edge technology and advanced research facilities to stay at the forefront of pharmaceutical innovation. They have forged a reputation for reliability and efficacy among healthcare professionals and patients alike. The company's product portfolio is remarkably diverse, spanning across essential therapeutic categories. From tackling infectious diseases with potent anti-infectives to providing relief for digestive ailments and enhancing eye health with specialised ophthalmic treatments, FDC offers a comprehensive range of solutions. They are also significant players in addressing chronic conditions, providing effective cardiovascular and anti-diabetic therapies. With a keen eye on evolving health challenges, FDC develops innovative respiratory care products, supports women's health through gynaecological solutions, and offers specialised dermatological treatments. FDC also manufactures vital supplements and trusted analgesics to further support overall well-being and quality of life. FDC's commitment extends beyond manufacturing and distribution. They have cultivated strong relationships with healthcare providers, researchers, and regulatory bodies to foster collaboration and knowledge sharing. FDC dedicates resources to patient education programs, empowering individuals to make informed decisions about their health. Their dedication to ethical practices, environmental sustainability, and social responsibility are cornerstones of their business philosophy. FDC strives to be a trusted partner in global healthcare, dedicated to enhancing lives and providing accessible, effective pharmaceutical solutions to a global patient population.

Company Details

Symbol:FDC
Industry:Pharmaceuticals
Sector:Pharmaceuticals
Website:https://www.fdcindia.com

Key Leadership

Dr. Nandan Mohan Chandavarkar
Joint MD & Executive Director
Mr. Mohan Anand Chandavarkar
BR Head, MD & Director
Mr. Ameya Ashok Chandavarkar
CEO of International Business & Executive Director

Corporate Events

Recent
Ex-Dividend Date
2024-11-22

FDC Share Price: Frequently Asked Questions

What is the current share price of FDC Ltd (FDC)?

As of 30 Mar 2026, 12:05 pm IST, FDC Ltd share price is ₹321.10. The FDC stock has a market capitalisation of ₹6.65K (Cr) on NSE/BSE.

Is FDC share price Overvalued or Undervalued?

FDC share price is currently trading at a P/E ratio of 29.48x, compared to the industry average of 31.77x. Based on this relative valuation, the FDC Ltd stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of FDC share price?

The 52-week high of FDC share price is ₹527.80 and the 52-week low is ₹317.75. These values are updated daily from NSE/BSE price data.

What factors affect the FDC Ltd share price?

Key factors influencing FDC share price include quarterly earnings growth (Sales Growth: -7.94%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is FDC Ltd a good stock for long-term investment?

FDC Ltd shows a 5-year Profit Growth of 1.92% and an ROE of 11.83%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.01 before investing in FDC shares.

How does FDC Ltd compare with its industry peers?

FDC Ltd competes with major peers in the Pharmaceuticals. Investors should compare FDC share price P/E of 29.48x and ROE of 11.83% against the industry averages to determine competitive standing.

What is the P/E ratio of FDC and what does it mean?

FDC share price has a P/E ratio of 29.48x compared to the industry average of 31.77x. Investors pay ₹29 for every ₹1 of annual earnings.

How is FDC performing according to Bull Run's analysis?

FDC has a Bull Run fundamental score of 40.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does FDC belong to?

FDC operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting FDC Ltd share price.

What is Return on Equity (ROE) and why is it important for FDC?

FDC has an ROE of 11.83%, which shows decent profitability but room for improvement. ROE measures how efficiently FDC Ltd generates profits from shareholders capital.

How is FDC debt-to-equity ratio and what does it indicate?

FDC has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk.

What is FDC dividend yield and is it a good dividend stock?

FDC offers a dividend yield of 1.23%, meaning you receive ₹1.23 annual dividend for every ₹100 invested in FDC Ltd shares.

How has FDC share price grown over the past 5 years?

FDC has achieved 5-year growth rates of: Sales Growth 9.46%, Profit Growth 1.92%, and EPS Growth 2.92%.

What is the promoter holding in FDC and why does it matter?

Promoters hold 69.66% of FDC shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in FDC Ltd.

What is FDC market capitalisation category?

FDC has a market capitalisation of ₹6645 crores, placing it in the Mid-cap category.

How volatile is FDC stock?

FDC has a beta of N/A. A beta > 1 suggests the FDC Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is FDC operating profit margin trend?

FDC has a 5-year average Operating Profit Margin (OPM) of 17.28%, indicating the company's operational efficiency.

How is FDC quarterly performance?

Recent quarterly performance shows FDC Ltd YoY Sales Growth of -7.94% and YoY Profit Growth of -60.62%.

What is the institutional holding pattern in FDC?

FDC has FII holding of 2.43% and DII holding of 6.81%. Significant institutional holding often suggests professional confidence in the FDC Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about FDC Ltd

What is the current share price of FDC Ltd?

FDC Ltd (FDC) trades at ₹321.10 on NSE and BSE. Market cap ₹6.65K (Cr). Educational data only.

What is the P/E ratio of FDC Ltd?

FDC Ltd has a P/E of 29.48x vs industry average 31.77x.

What is the Bull Run score for FDC Ltd?

FDC Ltd has a Bull Run score of 40.9/100 based on 25+ financial parameters.

Does FDC Ltd pay dividends?

FDC Ltd has a dividend yield of 1.23%. Past dividends don't guarantee future payments.

What is the ROE of FDC Ltd?

FDC Ltd has ROE of 11.83%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of FDC Ltd?

FDC Ltd has debt-to-equity of 0.01.

Is FDC Ltd a good investment?

Bull Run gives FDC Ltd a score of 40.9/100. This is not investment advice — consult a SEBI-registered advisor.